Endo to Participate at Citi 15th Annual BioPharma Virtual Conference
Endo International plc (NASDAQ: ENDP) will participate in the Citi 15th Annual BioPharma Virtual Conference from September 8-10, 2020. Management will host virtual meetings on September 10, 2020. Endo is a specialty pharmaceutical company focused on improving lives through quality therapies. Based in Dublin, Ireland, with U.S. headquarters in Malvern, Pennsylvania, Endo collaborates globally to develop life-enhancing treatments. More details can be found at www.endo.com.
- None.
- None.
DUBLIN, Sept. 8, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that it will participate in the Citi 15th Annual BioPharma Virtual Conference being held September 8-10, 2020. Members of management will host virtual meetings at the Conference on September 10, 2020.
About Endo International plc
Endo International plc (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Endo has global headquarters in Dublin, Ireland and U.S. headquarters in Malvern, Pennsylvania. Learn more at www.endo.com.
View original content:http://www.prnewswire.com/news-releases/endo-to-participate-at-citi-15th-annual-biopharma-virtual-conference-301125899.html
SOURCE Endo International plc
FAQ
What is the date of Endo's participation in the Citi BioPharma Virtual Conference?
What stock symbol is Endo International plc listed under?
Where is Endo International plc headquartered?
What type of company is Endo International plc?